Participant outcomes and preferences in Alzheimer's disease clinical trials: The electronic Person-Specific Outcome Measure (ePSOM) development program

INTRODUCTION: Current pharmacological interventions for Alzheimer's dementia delay symptom progression for about a year. Although the outcomes in earlier disease states may include changes in biomarkers, the clinical effectiveness of any intervention can ultimately only be assessed by a patient...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Alzheimers Dement (N Y)
Egile Nagusiak: Saunders, Stina, Muniz-Terrera, Graciela, Watson, Julie, Clarke, Charlotte L., Luz, Saturnino, Evans, Alison R., Ritchie, Craig W.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Elsevier 2018
Gaiak:
Perspective
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6296160/
https://ncbi.nlm.nih.gov/pubmed/30581975
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trci.2018.10.013
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak